Search

everythinglearnresearchcommunity

for

Search:↓

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Bardet-Biedl syndrome may include under-recognized skin problems related to its metabolic disturbances.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Injecting endometrial cells and PRP can improve pregnancy chances in ART.

The rash resolved after stopping ponatinib.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

Platelet-rich plasma injections can effectively treat stubborn alopecia areata.

The document concludes that specific hair and blood vessel abnormalities in infants with seizures and developmental issues may indicate Menkes disease, which lacks a cure and is often fatal by age 3.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

DCPA is a chronic skin condition affecting the legs, often misdiagnosed, and needs more research for better understanding and treatment.

Finasteride may help treat hidradenitis suppurativa in children, but concerns exist about ethics, safety, and proper use.

IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.

Topical cyclosporin-A is recommended for severe alopecia areata.

Collagenous gastritis is a rare condition causing chronic diarrhea and weight loss, often misdiagnosed due to nonspecific symptoms.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.